Ambu A/S (AMBU-B.CO)
DKK 121.0
(3.86%)
DKK 121.0
(3.86%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 584 Million DKK | -68.35% |
| 2022 | 1.84 Billion DKK | 124.18% |
| 2021 | 823 Million DKK | -43.01% |
| 2020 | 1.44 Billion DKK | 25.02% |
| 2019 | 1.15 Billion DKK | -11.7% |
| 2018 | 1.3 Billion DKK | 66.41% |
| 2017 | 786 Million DKK | -20.61% |
| 2016 | 990 Million DKK | 27.09% |
| 2015 | 779 Million DKK | -5.58% |
| 2014 | 825 Million DKK | 6.45% |
| 2013 | 775 Million DKK | 745.33% |
| 2012 | 91.68 Million DKK | -21.06% |
| 2011 | 116.14 Million DKK | -2.18% |
| 2010 | 118.72 Million DKK | -2.91% |
| 2009 | 122.28 Million DKK | -3.23% |
| 2008 | 126.36 Million DKK | -13.55% |
| 2007 | 146.17 Million DKK | -14.67% |
| 2006 | 171.31 Million DKK | -37.15% |
| 2005 | 272.54 Million DKK | 52.78% |
| 2004 | 178.39 Million DKK | -11.72% |
| 2003 | 202.07 Million DKK | -10.45% |
| 2002 | 225.64 Million DKK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 628 Million DKK | 7.53% |
| 2024 Q3 | 612 Million DKK | -2.86% |
| 2024 Q2 | 630 Million DKK | 0.32% |
| 2023 FY | 584 Million DKK | -68.35% |
| 2023 Q2 | 915 Million DKK | -52.88% |
| 2023 Q1 | 1.94 Billion DKK | 5.26% |
| 2023 Q4 | 584 Million DKK | -21.51% |
| 2023 Q3 | 744 Million DKK | -18.69% |
| 2022 Q2 | 1.52 Billion DKK | 9.21% |
| 2022 Q4 | 1.84 Billion DKK | 19.11% |
| 2022 Q3 | 1.54 Billion DKK | 1.31% |
| 2022 FY | 1.84 Billion DKK | 124.18% |
| 2022 Q1 | 1.4 Billion DKK | 70.11% |
| 2021 FY | 823 Million DKK | -43.01% |
| 2021 Q1 | 1.87 Billion DKK | 29.78% |
| 2021 Q3 | 764 Million DKK | 25.04% |
| 2021 Q4 | 823 Million DKK | 7.72% |
| 2021 Q2 | 611 Million DKK | -67.4% |
| 2020 Q3 | 1.33 Billion DKK | -10.18% |
| 2020 Q1 | 1.48 Billion DKK | 28.4% |
| 2020 Q2 | 1.48 Billion DKK | 0.07% |
| 2020 FY | 1.44 Billion DKK | 25.02% |
| 2020 Q4 | 1.44 Billion DKK | 8.33% |
| 2019 Q2 | 1.31 Billion DKK | -3.24% |
| 2019 FY | 1.15 Billion DKK | -11.7% |
| 2019 Q1 | 1.35 Billion DKK | 3.67% |
| 2019 Q4 | 1.15 Billion DKK | 1.49% |
| 2019 Q3 | 1.13 Billion DKK | -13.26% |
| 2018 Q4 | 1.3 Billion DKK | -8.98% |
| 2018 FY | 1.3 Billion DKK | 66.41% |
| 2018 Q1 | 1.04 Billion DKK | 32.7% |
| 2018 Q2 | 1.36 Billion DKK | 30.39% |
| 2018 Q3 | 1.43 Billion DKK | 5.66% |
| 2017 Q3 | 954 Million DKK | -8.27% |
| 2017 FY | 786 Million DKK | -20.61% |
| 2017 Q4 | 786 Million DKK | -17.61% |
| 2017 Q2 | 1.04 Billion DKK | -8.61% |
| 2017 Q1 | 1.13 Billion DKK | 14.95% |
| 2016 Q4 | 990 Million DKK | 6.91% |
| 2016 Q2 | 1.05 Billion DKK | 10.61% |
| 2016 Q1 | 952 Million DKK | 22.21% |
| 2016 Q3 | 926 Million DKK | -12.06% |
| 2016 FY | 990 Million DKK | 27.09% |
| 2015 Q3 | 884 Million DKK | -6.06% |
| 2015 Q1 | 917 Million DKK | 11.15% |
| 2015 Q4 | 779 Million DKK | -11.88% |
| 2015 FY | 779 Million DKK | -5.58% |
| 2015 Q2 | 941 Million DKK | 2.62% |
| 2014 Q2 | 826 Million DKK | -2.71% |
| 2014 Q3 | 889 Million DKK | 7.63% |
| 2014 Q4 | 825 Million DKK | -7.2% |
| 2014 FY | 825 Million DKK | 6.45% |
| 2014 Q1 | 849 Million DKK | 9.55% |
| 2013 Q4 | 775 Million DKK | -8.06% |
| 2013 FY | 775 Million DKK | 745.33% |
| 2013 Q1 | - DKK | -100.0% |
| 2013 Q2 | 770.8 Million DKK | 0.0% |
| 2013 Q3 | 842.9 Million DKK | 9.35% |
| 2012 FY | 91.68 Million DKK | -21.06% |
| 2012 Q4 | 91.68 Million DKK | -40.43% |
| 2012 Q3 | 153.9 Million DKK | 4.48% |
| 2012 Q2 | 147.3 Million DKK | -8.57% |
| 2012 Q1 | 161.1 Million DKK | 38.71% |
| 2011 FY | 116.14 Million DKK | -2.18% |
| 2011 Q1 | 160.8 Million DKK | 35.44% |
| 2011 Q2 | 134.4 Million DKK | -16.42% |
| 2011 Q3 | 133.5 Million DKK | -0.67% |
| 2011 Q4 | 116.14 Million DKK | -13.0% |
| 2010 Q4 | 118.72 Million DKK | -7.96% |
| 2010 FY | 118.72 Million DKK | -2.91% |
| 2010 Q1 | - DKK | -100.0% |
| 2010 Q3 | 129 Million DKK | -7.33% |
| 2010 Q2 | 139.2 Million DKK | 0.0% |
| 2009 Q4 | 122.28 Million DKK | 0.0% |
| 2009 FY | 122.28 Million DKK | -3.23% |
| 2008 FY | 126.36 Million DKK | -13.55% |
| 2007 FY | 146.17 Million DKK | -14.67% |
| 2006 FY | 171.31 Million DKK | -37.15% |
| 2005 FY | 272.54 Million DKK | 52.78% |
| 2004 FY | 178.39 Million DKK | -11.72% |
| 2003 FY | 202.07 Million DKK | -10.45% |
| 2002 FY | 225.64 Million DKK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| ChemoMetec A/S | 4.15 Million DKK | -13955.355% |
| Demant A/S | 14.45 Billion DKK | 95.96% |
| GN Store Nord A/S | 13.49 Billion DKK | 95.674% |
| Scandinavian Medical Solutions A/S | 28.6 Million DKK | -1941.701% |
| ViroGates A/S | 5.3 Million DKK | -10918.868% |